Conceptio
›
circulating-tumor-dna
Topic
circulating-tumor-dna
Knowledge-graph topic
· documents ABOUT circulating-tumor-dna across the archive
50
Documents about circulating-tumor-dna
Documents about circulating-tumor-dna
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study
#274213
HAL (France)
Specificity and Sensitivity of Circulating Tumor HPV-DNA in Patients with HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
#409335
NCBI PubMed Central
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
#849695
ClinicalTrials.gov
Circulating Tumor DNA Monitoring in Breast Cancer Undergoing Neoadjuvant Therapy
#851218
ClinicalTrials.gov
Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
#804968
ClinicalTrials.gov
On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
#918583
ClinicalTrials.gov
Early Assessment of Response to Treatment of Metastatic LUng Tumors Based on CIrculating Tumor DNA
#123456
ClinicalTrials.gov
Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults
#475963
HAL (France)
Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer
#828988
ClinicalTrials.gov
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
#127606
ClinicalTrials.gov
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
#452340
Lund University Publications
CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II
#848921
ClinicalTrials.gov
Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer
#893922
ClinicalTrials.gov
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
#980796
ClinicalTrials.gov
Prognostic Impact of Blood Tumor Mutational Burden in pMMR/MSS Metastatic Colorectal Cancer Assessed by FoundationOne® Liquid CDx
#315023
HAL (France)
Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
#855254
ClinicalTrials.gov
Circulating Tumor DNA Methylation Test to Differentiate Benign and Malignant Pulmonary Nodules
#879245
ClinicalTrials.gov
OPTIMIzation of Treatment SElection and Follow up in Oligometastatic Colorectal Cancer
#992031
ClinicalTrials.gov
Liquid Biopsy of Non-Plasma Body Fluids in Non-Small Cell Lung Cancer: Look Closer to the Tumor!
#178212
HAL (France)
Implementing Circulating Tumor DNA Analysis at Initial Diagnosis to Improve Management of Advanced NSCLC Patients
#831093
ClinicalTrials.gov
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
#325302
ClinicalTrials.gov
Postoperative circulating tumor DNA detection is associated with the risk of recurrence in patients resected for a stage II colorectal cancer
#670098
HAL (France)
Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases
#878456
ClinicalTrials.gov
Integrating Artificial Intelligence, Circulating Tumor DNA, and Real-World Evidence to Optimize Hematologic Clinical Trials: Toward Adaptive and Learning Trial Designs.
#9131
NCBI PubMed Central
Circulating Tumor DNA as a Biomarker of Treatment Response and Minimal Residual Disease in Diffuse Large B-Cell Lymphoma: A Literature Review.
#409294
NCBI PubMed Central
Diagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary Nodules
#841226
ClinicalTrials.gov
Circulating Tumor DNA Guided Boost Therapy in Early Triple Negative Breast Patients With Residual Disease After Neoadjuvant Therapy
#121370
ClinicalTrials.gov
An End-to-End Synthetic Oncology Clinical Trial Framework Integrating Radiographic Response, Circulating Tumor DNA, Safety, and Survival for Decision-Oriented Clinical Data Science
#160452
bioRxiv / medRxiv
Perioperative Adebrelimab for Locally Advanced Cervical Cancer
#877894
ClinicalTrials.gov
An End-to-End Synthetic Oncology Clinical Trial Framework Integrating Radiographic Response, Circulating Tumor DNA, Safety, and Survival for Decision-Oriented Clinical Data Science
#164879
Unpaywall
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
#813975
ClinicalTrials.gov
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
#884239
ClinicalTrials.gov
Smartphone-enabled Hybrid Identification of Early CoLorectal Disease Using Blood-Based Cancer Testing Across TeXas
#968744
ClinicalTrials.gov
Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
#261506
ClinicalTrials.gov
Evaluation of circulating tumor DNA as a prognostic and predictive biomarker in BRAF V600E mutated colorectal cancer—results from the FIRE ‐4.5 study
#326127
HAL (France)
ALFAssay: A feed‑forward neural network for quantitative fragmentomics‑based ctDNA profiling in breast cancer
#406546
PLOS
Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer
#836998
ClinicalTrials.gov
ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
#853174
ClinicalTrials.gov
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
#807736
ClinicalTrials.gov
Data-driven modeling in healthcare: From generative AI in healthcare education to epidemiological and ovarian cancer biomarker modeling
#348773
RUcore, Rutgers University Community Repository
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC
#811484
ClinicalTrials.gov
Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy
#907623
ClinicalTrials.gov
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
#895023
ClinicalTrials.gov
CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.
#865111
ClinicalTrials.gov
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
#806925
ClinicalTrials.gov
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
#830790
ClinicalTrials.gov
EGFR Mutations on ctDNA in Patients With Advanced NSCLC
#871208
ClinicalTrials.gov
Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical Trial
#858144
ClinicalTrials.gov
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
#474773
ClinicalTrials.gov
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
#893493
ClinicalTrials.gov
← Previous
Page 2 of 3
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.